J&J says will submit 10 medicines to regulators by 2019
May 20, 2015 at 09:20 AM EDT
NEW YORK, May 20 (Reuters) - Drugmaker Johnson & Johnson said on Wednesday that it would submit 10 new medicines to regulators by 2019, forecasting that many of the drugs in its research and development pipeline will have more than $1 billion in peak annual sales.
